Evidence map›Paper›PMID 35003312›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Applying Four-Step Characteristic Ion Filtering with HPLC-Q-Exactive MS/MS Spectrometer Approach for Rapid Compound Structures Characterization and Major Representative Components Quantification in Modified Tabusen-2 Decoction.

Yu Zhao, Xin Dong, Zhi Wang, Rui Dong, Ren Bu, Qianxi Feng, Peifeng Xue, Bi Qu

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu ZhaoDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Xin DongDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Zhi WangDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Rui DongDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Ren BuDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Qianxi FengDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Peifeng XueDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.ORCID https://orcid.org/0000-0002-5702-5263
Bi QuDepartment of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.ORCID https://orcid.org/0000-0003-3177-2639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modified Tabusen-2 decoction (MTBD) is traditional Chinese Mongolia medicine, mainly used to treat osteoporosis. However, the precise material basis of this prescription is not yet fully elucidated. Herein, we establish an HPLC-Q-Exactive MS/MS spectrometer method with four-step characteristic ion filtering (FSCIF) strategy to quickly and effectively identify the structural features of MTBD and determine the representative compounds content. The FSCIF strategy included database establishment, characteristic ions summarization, neutral loss fragments screening, and secondary mass spectrum fragment matching four steps. By using this strategy, a total of 143 compounds were unambiguously or tentatively annotated, including 5 compounds which were first reported in MTBD. Nineteen representative components were simultaneously quantified with the HPLC-Q-Exactive MS/MS spectrometer, and it is suitable for eight batches of MTBD. Methodology analysis showed that the assay method had good repeatability, accuracy, and stability. The method established above was successfully applied to assess the quality of MTBD extracts. Collectively, our findings enhance our molecular understanding of the MTBD formulation and will allow us to control its quality in a better way. At the same time, this study can promote the development and utilization of ethnic medicine.

Identifiers

PMID35003312
PMCPMC8741372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.